European Journal of Cancer
Volume 38, Issue 10 , Pages 1365-1377 , July 2002

Emergencies and their management

  • G Nicolin

      Affiliations

    • Corresponding Author InformationTel.: +44-1865-221-066; fax: +44-1865-221-083
    • Clinical lecturer.

Received 17 January 2001 ,Revised 12 February 2002 ,Accepted 19 February 2002.

References 

  1. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome (a review of 37 patients with Burkitt's lymphoma). Am J. Med. 1980;68:486–491
  2. Jones DP, Mahmoud H, Chesney RW. Tumor lysis syndrome (pathogenesis and management). Pediatr Nephrol. 1995;9:206–212
  3. Griffen TC, Bowman P, Winick NJ, Buchanan GR. Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood (further experience with total therapy). Med Pediatr. Oncol. 1994;23:393–399
  4. Stapleton FB, Strother DR, Roy S, Wyatt RJ, McKay CP, Murphy SB. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics. 1988;82:863–869
  5. Rieselbach RE, Bentzel CJ, Cotlove E, Frei E, Freirich EJ. Uric acid excretion and renal function in the acute hyperuricemia of leukemia (pathogenesis and therapy of uric acid nephropathy). Am J. Med. 1964;37:872–884
  6. Andreoli SP, Clark JH, McGuire WA, Bergstein JM. Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol (relationship to acute renal failure). J. Pediatr. 1986;109:292–298
  7. Veenstra J, Krediet RT, Somers R, et al.  Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. Neth. J. Med. 1994;45:211–216
  8. Ten Harkel ADJ, Kist-Van Holthe JE, van Weel M, et al.  Alkalinization and the tumor lysis syndrome. Med Ped. Oncol. 1998;31:27–28
  9. Smalley RV, Guaspari A, Haase-Statz S, Anderson SA, Cederberg D, Hohneker JA. Allopurinol (intravenous use for prevention and treatment of hyperuricaemia). J. Clin. Oncol. 2000;18:1758–1763
  10. Mahmoud HH, Leverger G, Patte C, Harvey E, Lascombes F. Advances in the management of malignancy-associated hyperuricaemia. Br J. Cancer. 1998;77(Suppl. 4):18–20
  11. Pui CH, Relling MV, Lascombes F, et al.  Urate oxidase in prevention and treatment of hyperuricaemia associated with lymphoid malignancies. Leukemia. 1997;11:1813–1816
  12. Deger GE, Wagoner RD. Peritoneal dialysis in acute uric acid nephropathy. Mayo Clin. Proc. 1972;47:189–192
  13. Heney D, Essex-Cater A, Brocklebank JT, Bailey CC, Lewis IJ. Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome. Pediatr Nephrol. 1990;4:245–247
  14. Saccente SL, Kohaut EC, Berkow RL. Prevention of tumor lysis syndrome using continuous veno-venous haemofiltration. Pediatr Nephrol. 1995;9:569–573
  15. McKay C, Furman WL. Hypercalcemia complicating childhood malignancies. Cancer. 1993;72:256–260
  16. LeBlanc A, Caillaud JM, Hartmann O, et al.  Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. Cancer. 1984;54:2132–2136
  17. Vujanic GM, Sandstedt B, Harms D, Boccon-Gibod L, Delemarre JF. Rhabdoid tumour of the kidney (a clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file). Histopathology. 1996;28:333–340
  18. Ralston S. Pathogenesis of humoral hypercalcaemia of malignancy. Lancet. 1987;ii:1443–1445
  19. Mitchell CD, Harvey W, Gordon D, Womer RB, Dillon MJ, Pritchard J. Rhabdoid Wilms' tumour and prostaglandin-mediated hypercalcaemia. Eur Paediatr. Haematol. Oncol. 1985;2:153–157
  20. Ritch PS. Treatment of cancer-related hypercalcaemia. Semin Oncol. 1990;17(Suppl. 5):26–33
  21. Young G, Shende A. Use of pamidronate in the management of acute cancer-related hypercalcemia in children. Med Pediatr. Oncol. 1998;30:117–121
  22. Srivastava T, Alon US. Bisphosphonates (from grandparents to grandchildren). Clin. Pediatr. Phila. 1999;38:687–702
  23. Wurthner JU, Kohler G, Behringer D, Lindemann A, et al.  Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis (a clinicopathologic report of four cases). Cancer. 1999;85:368–374
  24. Kelly KM, Lange B. Oncologic emergencies. Pediatric Clinics of North America. 1997;44:809–830
  25. Basade M, Dhar AK, Kulkarni SS, et al.  Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy. Med Pediatr. Oncol. 1995;25:204–207
  26. Bunin NJ, Kunkel K, Callihan TR. Cytoreductive procedures in the early management in cases of leukemia and hyperleukocytosis in children. Med Pediatr. Oncol. 1987;15:232–235
  27. Hume HA. Transfusion support of children with hematologic and oncologic disorders. In:  Petz LD,  Swisher SN,  Kleinmans R,  Spence RIC,  Strauss RG editor. Clinical Practice of Transfusion Medicine. 3rd edn. New York: Churchill Livingstone; 1996;p. 705–732
  28. Hume HA. Blood components (preparation, indications and administration). In:  Lilleyman J,  Hann I,  Blanchette V editor. Pediatric Hematology. 2nd edn. London: Churchill Livingstone; 1999;p. 709–740
  29. Ribeiro RC, Pui CH. The clinical and biological correlates of coagulopathy in children with acute leukemia. J. Clin. Oncol. 1986;4:1212–1218
  30. Pui CH, Behm FG. Pathology of acute myeloid leukemia. In:  Lilleyman J,  Hann I,  Blanchette V editor. Pediatric Hematology. 2nd edn. London: Churchill Livingstone; 1999;p. 369–385
  31. Tallman MS, Hakiman D, Kwaan HC, Rickles FR. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia. Leuk Lymphoma. 1993;11:27–36
  32. Bapna A, Nair R, Tapan KS, et al.  All-trans retinoic acid (ATRA) (pediatric acute promyelocytic leukemia). Pediatr Hematol. Oncol. 1998;15:243–248
  33. Dompret H, Scroboaci ML, Ghorra P, et al.  Coagulation disorders associated with acute promyelocytic leukemia (corrective effect of all-trans retinoic acid). Leukemia. 1993;7:2–9
  34. Di Bona E, Avvisati G, Castaman G, et al.  Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukemia. Br. J. Haematol. 2000;108:689–695
  35. Fenaux P, Le Deley MC, Castaigne S, et al.  Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood. 1993;82:3241–3249
  36. Tallman MS, Andersen JW, Shiffer CA, et al.  All-trans retinoic acid in acute promyelocytic leukemia. NEJM. 1997;337:1021–1028
  37. King RM, Telander RL, Smithson WA, Banks PM, Han M-T. Primary mediastinal tumors in children. J. Pediatr. Surg. 1982;17:512–520
  38. Ferrari LR, Bedford RF. General anesthesia prior to treatment of anterior mediastinal masses in pediatric cancer patients. Anesthesiology. 1990;72:991–995
  39. Azizkhan RG, Dudgeon DL, Buck JR, et al.  Life threatening airway obstruction as a complication to the management of mediastinal masses in children. J. Pediatr. Surg. 1985;20:816–822
  40. Bittar D. Respiratory obstruction associated with induction of general anesthesia in a patient with mediastinal Hodgkin's disease. Anesth. Analg. 1975;54:399–403
  41. Northrip D, Bohman B, Tuesada K. Total airway occlusion and superior vena cava syndrome in a child with anterior mediastinal tumor. Anesth. Analg. 1986;65:1079–1082
  42. Levin H, Bursztein S, Heifetz M. Cardiac arrest in a child with an anterior mediastinal mass. Anesth. Analg. 1985;64:1129–1130
  43. Halpern S, Chatten J, Meadows AT, et al.  Anterior mediastinal masses (anesthesia hazards and other problems). J. Pediatr. 1983;102:407
  44. Loeffler JS, Leopold KA, Recht A, et al.  Emergency prebiopsy radiation for mediastinal masses (impact on subsequent pathologic diagnosis and outcome). J. Clin. Oncol. 1986;4:716
  45. Shamberger RC, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ, Wold ME. CT quantitation of tracheal cross-sectional area as a guide to the surgical and anesthetic management of children with anterior mediastinal masses. J. Pediatr. Surg. 1991;26:138–142
  46. Miller RD, Hyatt RE. Evaluation of obstructing lesions of the trachea and larynx by flow-volume loops. Am. Rev. Respir. Dis. 1973;108:475–481
  47. Piro A, Weiss D, Hellman S. A possible danger for intubation anesthesia. Int. J. Radiat. Oncol. Bio. Phys. 1976;1:415–419
  48. Klein SL, Sanford RA, Mulbauer MS. Pediatric spinal epidural metastases. J. Neurosurg. 1991;74:70–75
  49. Lewis DW, Packer RJ, Raney B, Rak IW, Belasco J, Lange B. Incidence, presentation and outcome of spinal cord disease in children with systemic cancer. Pediatrics. 1986;78:438–443
  50. Raffel C, Neave VCD, Lavine S, McComb JG. Treatment of spinal cord compression by epidural malignancy in childhood. Neurosurgery. 1991;28:349–352
  51. Manabe S, Tanaka H, Higo Y, et al.  Experimental analysis of the spinal cord compressed by spinal metastasis. Spine. 1989;14:1308
  52. Byrne TN. Spinal cord compression from epidural metastases. N. Engl. J. Med. 1992;327:614
  53. Conrad EU, Olszewski AD, Berger M, Powell E, Bruckner J. Pediatric spine tumors with spinal cord compromise. J. Pediatr. Orthop. 1992;12:454–460
  54. Carmody RF, Yang PJ, Seeley GW, et al.  Spinal cord compression due to metastatic disease: diagnosis with MR imaging versus myelography. Radiology. 1989;173:225
  55. Smoker WRK, Godersky JC, Knutzon RK, et al.  The role of MR imaging in evaluating metastatic spinal disease. Am. J. Roentgenol. 1987;149:1241
  56. Sanderson IR, Pritchard J, Marsh HT. Chemotherapy as the initial treatment of spinal cord compression due to disseminated neuroblastoma. J. Neurosurg. 1989;70:688–690
  57. Delattre JY, Arbit E, Thaler HT, et al.  A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J. Neurosurg. 1989;70:920
  58. Raimondi AJ, Gutierrez FA, Di Rocco C. Laminotomy and total reconstruction of the posterior spinal arch for spinal canal surgery in childhood. J. Neurosurg. 1976;45:555–560
  59. Mayfield JK, Riseborough EJ, Jaffe N, et al.  Spinal deformity in children treated for neuroblastoma. The effect of radiation and other forms of treatment. J. Bone Joint Surg. (Am.). 1981;63:183–193
  60. Riseborough EJ, Grabias SL, Burton RI, et al.  Skeletal alterations following irradiation for Wilm's tumor. J. Bone Joint Surg. (Am.). 1976;58:526–536
  61. Hoover M, Bowman LC, Crawford SE, et al.  Long-term outcome of patients with intraspinal neuroblastoma. Med. Pediatr. Oncol. 1999;32:353–359
  62. Plantaz D, Rubie H, Michon J, et al.  The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. Cancer. 1996;78:311–319
  63. Hayes FA, Thompson FI, Hvizdala E, et al.  Chemotherapy as an alternative to laminectomy and radiation in the management of epidural tumor. J. Pediatr. 1981;104:221–224

PII: S0959-8049(02)00072-2

European Journal of Cancer
Volume 38, Issue 10 , Pages 1365-1377 , July 2002

Article Tools

* Image Usage & Resolution